NasdaqGS - Nasdaq Real Time Price USD
Solid Biosciences Inc. (SLDB)
2.7600
-0.0100
(-0.36%)
At close: May 9 at 4:00:01 PM EDT
2.8500
+0.09
+(3.26%)
After hours: May 9 at 7:36:13 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 10 | 8 |
| Avg. Estimate | -0.54 | -0.5 | -2.12 | -1.95 |
| Low Estimate | -0.77 | -0.76 | -3.04 | -2.76 |
| High Estimate | -0.39 | -0.35 | -1.55 | -1.24 |
| Year Ago EPS | -0.64 | -0.61 | -3.06 | -2.12 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 11 | 10 |
| Avg. Estimate | -- | -- | -- | 1.84M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 18.4M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.6 | -0.66 | -0.66 | -0.78 |
| EPS Actual | -0.64 | -0.61 | -0.79 | -1 |
| Difference | -0.04 | 0.05 | -0.13 | -0.22 |
| Surprise % | -6.67% | 7.85% | -20.30% | -27.84% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.54 | -0.5 | -2.12 | -1.95 |
| 7 Days Ago | -0.54 | -0.5 | -2.12 | -1.95 |
| 30 Days Ago | -0.54 | -0.5 | -2.12 | -1.95 |
| 60 Days Ago | -0.61 | -0.57 | -2.38 | -2.22 |
| 90 Days Ago | -0.75 | -0.72 | -2.84 | -2.78 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 2 | 2 |
| Up Last 30 Days | 5 | 6 | 7 | 3 |
| Down Last 7 Days | 4 | 3 | 5 | 2 |
| Down Last 30 Days | 1 | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SLDB | 15.47% | 18.36% | 30.72% | 7.90% |
| S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Upgrades & Downgrades
| Maintains | JP Morgan: Overweight to Overweight | 3/13/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/10/2025 |
| Maintains | Chardan Capital: Buy to Buy | 3/7/2025 |
| Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 3/7/2025 |
| Maintains | Chardan Capital: Buy to Buy | 2/19/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/13/2025 |
Related Tickers
RGNX REGENXBIO Inc.
7.52
+5.17%
LXEO Lexeo Therapeutics, Inc.
2.6900
-10.33%
QURE uniQure N.V.
12.79
+4.41%
DYN Dyne Therapeutics, Inc.
11.41
+1.02%
CAPR Capricor Therapeutics, Inc.
6.34
-9.04%
MGTX MeiraGTx Holdings plc
5.42
-0.91%
LRMR Larimar Therapeutics, Inc.
2.1200
-5.36%
FHTX Foghorn Therapeutics Inc.
4.2000
-7.28%
JANX Janux Therapeutics, Inc.
25.56
-3.07%
KROS Keros Therapeutics, Inc.
13.65
-2.64%